Log in to save to my catalogue

The clinical utility and cost impact of cystatin C measurement in the diagnosis and management of ch...

The clinical utility and cost impact of cystatin C measurement in the diagnosis and management of ch...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_plos_journals_1965072124

The clinical utility and cost impact of cystatin C measurement in the diagnosis and management of chronic kidney disease: A primary care cohort study

About this item

Full title

The clinical utility and cost impact of cystatin C measurement in the diagnosis and management of chronic kidney disease: A primary care cohort study

Publisher

United States: Public Library of Science

Journal title

PLoS medicine, 2017-10, Vol.14 (10), p.e1002400-e1002400

Language

English

Formats

Publication information

Publisher

United States: Public Library of Science

More information

Scope and Contents

Contents

To reduce over-diagnosis of chronic kidney disease (CKD) resulting from the inaccuracy of creatinine-based estimates of glomerular filtration rate (GFR), UK and international guidelines recommend that cystatin-C-based estimates of GFR be used to confirm or exclude the diagnosis in people with GFR 45-59 ml/min/1.73 m2 and no albuminuria (CKD G3aA1)....

Alternative Titles

Full title

The clinical utility and cost impact of cystatin C measurement in the diagnosis and management of chronic kidney disease: A primary care cohort study

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_plos_journals_1965072124

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_plos_journals_1965072124

Other Identifiers

ISSN

1549-1676,1549-1277

E-ISSN

1549-1676

DOI

10.1371/journal.pmed.1002400

How to access this item